EGFR and glioblastoma: One example of this could be the association of kinin agonists with the recombinant monoclonal antibody Cetuximab (Erbitus; 152 kDa and 15 nm diameter; likewise, the 155 kDa TRIC-dextrans) targeting the EGFR that is overexpressed in more than 50% of patients with GBM.